Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C55H59N5O20 |
Molecular Weight | 1110.0785 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC3=C(C)C4=C(C=C3)C(O)=C(NC(=O)C5=CNC(C(=O)NC6=C(O)C7=C(OC6=O)C(C)=C(O[C@@H]8OC(C)(C)[C@H](OC)[C@@H](OC(=O)C9=CC=C(C)N9)[C@H]8O)C=C7)=C5C)C(=O)O4)OC1(C)C
InChI
InChIKey=WTIJXIZOODAMJT-DHFGXMAYSA-N
InChI=1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m1/s1
Molecular Formula | C55H59N5O20 |
Molecular Weight | 1110.0785 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Coumermycin is from the aminocoumarin class of antibiotic compounds which acts by inhibiting DNA gyrase. Coumermycin is effective against gram-positive bacteria, but not gram-negative bacteria. Coumermycin its derivatives have been studied since the 1950's as potential antibiotic. However, it has seen little to no clinical development because of its low water solubility, toxicity profile, and ineffectiveness against gram-negative bacteria.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2311224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/794878 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3164157
Lethal septicemia was induced in mice by intraperitoneal administration of Methicillin-Resistant Staphylococcus. The infection was successfully treated in 50% of the animals (ED50) following a dose of 0.9 micro-g/g body weight. This was significantly better than ofloxacin and vancomycin.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4391844
The antibiotic ability of coumermycin was evaluated against 232 bacterial strains. Minimal inhibitory concentrations (MIC) were determined in trypticase soy broth using twofold serial dilutions. The last tube in a series to show no visible growth after 18 hours at 37 deg-C was considered the MIC. Strain specific MIC's were reported between 0.002 micro-g/L and 100 micro-g/L.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:52:33 GMT 2023
by
admin
on
Sat Dec 16 15:52:33 GMT 2023
|
Record UNII |
PCH9QZ1IIH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3907
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
Coumermycin A1
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
DTXSID901023379
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
100000084272
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
54675768
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
SUB06814MIG
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
C81447
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
DB13912
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
4434-05-3
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
C004628
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908352
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
1948
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
PCH9QZ1IIH
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY | |||
|
107412
Created by
admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |